起始年龄、METAVIR评分、性别和替代建模假设对每获得质量调整生命年增量成本的影响
丙型肝炎治疗成本效果分析的表格数据集,涵盖患者特征、ICER、QALY等,评估起始年龄、METAVIR评分、性别和建模假设的影响。

基本信息
资源简介
起始年龄、METAVIR评分、性别和替代建模假设对每获得质量调整生命年增量成本的影响
【数据集背景】
本数据集源站标题为《Impact on Incremental Cost per QALY Gained of Starting Age, METAVIR Score, Sex, and Alternative Modeling Assumptions.》。源站首次发布:2014-03-06。
【数据内容】
源站原始描述:ICER indicates incremental cost-effectiveness ratio; PR, peginterferon alfa-2a plus ribavirin; QALY, quality-adjusted life-year; SVR, sustained virologic response; TVR, telaprevir. aThe base-case values and assumptions were as follows: patient population distribution by sex, age, and METAVIR fibrosis score from the ADVANCE and REALIZE clinical trials; lifetime time horizon; 3% annual discount rate; incremental difference in treatment-phase utility values for TVR+PR compared with PR alone of 0.01…
【数据结构与技术规格】
文件数 1 个,合计 9.73 KB。Table_4.xls:application/vnd.ms-excel,9.73 KB。数据集 DOI:10.1371/journal.pone.0090295.t004。
【主题与分类】
源站学科分类:Mathematics、Medicine、Sociology。主题标签:Probability theory、Markov model、Gastroenterology and hepatology、Liver diseases、Infectious hepatitis、Hepatitis C、Infectious diseases、Viral diseases、hepatitis、Non-clinical medicine。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://plos.figshare.com/articles/dataset/_Impact_on_Incremental_Cost_per_QALY_Gained_of_Starting_Age_METAVIR_Score_Sex_and_Alternative_Modeling_Assumptions_/953453
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:J. Brogan, Anita; E. Talbird, Sandra; Thompson, James R.; Miller, Jeffrey D.; Rubin, Jaime; Deniz, Baris (2015). Impact on Incremental Cost per QALY Gained of Starting Age, METAVIR Score, Sex, and Alternative Modeling Assumptions.. PLOS ONE. Dataset
【使用注意】
· 源站最后修改于 2023-06-06,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Impact on Incremental Cost per QALY Gained of Starting Age, METAVIR Score, Sex, and Alternative Modeling Assumptions.
- DOI:10.1371/journal.pone.0090295.t004
- 发布日期:2014-03-06
- 文件数:1 个
- 文件总体积:9.73 KB
- 源站页面:https://plos.figshare.com/articles/dataset/_Impact_on_Incremental_Cost_per_QALY_Gained_of_Starting_Age_METAVIR_Score_Sex_and_Alternative_Modeling_Assumptions_/953453
命令行下载
curl -L -o "Table_4.xls" "https://ndownloader.figshare.com/files/1409389"
文件清单
Table_4.xls(9.73 KB)
文件总体积 9.73 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
ICER indicates incremental cost-effectiveness ratio; PR, peginterferon alfa-2a plus ribavirin; QALY, quality-adjusted life-year; SVR, sustained virologic response; TVR, telaprevir.
aThe base-case values and assumptions were as follows: patient population distribution by sex, age, and METAVIR fibrosis score from the ADVANCE and REALIZE clinical trials; lifetime time horizon; 3% annual discount rate; incremental difference in treatment-phase utility values for TVR+PR compared with PR alone of 0.01 for treatment-naïve patients and prior relapsers and –0.03 for prior partial responders and prior null responders; utility value of 0.87 for health states F0 to F4 if SVR was achieved; and clinical assumption that patients with advanced fibrosis (F3-F4) remained at risk for further liver deterioration even if SVR is achieved; probability of death after liver transplant of 0.210 in first year, 0.057 in years 2+.
bTVR+PR dominates PR alone, with more QALYs at a lower total cost.
cThe subgroup of male prior partial responders in the PR arm of REALIZE was very small (n = 15). The high ICER for this subgroup was the result of the SVR achieved by the 1 male with baseline fibrosis score F4. Caution should be exercised in interpreting this ICER.
dBased on estimates reported in Thein et al., 2009 [42].
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0090295.t004(source: https://plos.figshare.com/articles/dataset/_Impact_on_Incremental_Cost_per_QALY_Gained_of_Starting_Age_METAVIR_Score_Sex_and_Alternative_Modeling_Assumptions_/953453)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




